Bli medlem
Bli medlem

Du är här

2021-10-25

Scandinavian ChemoTech's subsidiary Vetiqure has received a preliminary positive treatment result

Preliminary results of the first TSE treatment at Evidensia Specialistdjursjukhuset Helsingborg point to a result that is better than expected.

The patient is a dog with a tumour in the palate roof where previous radiotherapy and local chemotherapy have been shown to have insufficient effect.

"We are awaiting more information but continue to view the development very positively." -says veterinarian Majbritt Larsen, who is responsible for the Oncology team in Helsingborg

This disclosure contains information that ChemoTech is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 25-10-2021 16:30 CET.

For more information, please contact:

Mohan Frick, CEO

Phone: +46 (0)10-218 93 00

info@chemotech.se

Certified Adviser: Erik Penser Bank, Tel: +46 8 463 80 00, E-mail: certifiedadviser@penser.se

Författare Cision